| |
 |
|
| Medicines and their intimate interaction with human physiology, makes product responsibility paramount. Even though the efficacy, safety and stability of the active ingredient in our generics is well established, we still have in place a well-organised and alert pharmacovigilance department to monitor and evaluate any Adverse Drug Reactions (ADRs). |
|
| We provide our customers and users with the highest possible degree of transparency and inform them about the composition and effects of our pharmaceutical products. The quality, benefits and safety - including reliable storage and supply are integral to our drugs. |
|
| All our products meet regulatory and safety standards and approvals. Besides this our facilities and products are periodically inspected by various regulatory authorities such as the U.S. FDA, the UK MHRA, the South African Medicines Control Council, the Brazilian ANVISA, the Romanian National Medicines Agency, the Gulf Co-operation Council group, the Ministry of Health of Kyrgyzstan and the World Health Organisation (WHO). |
|
| |
|
|
Our two pronged quality
assurance, as detailed
below, ensures consistent
quality from development
to dispatch. |
|
| Development Quality Assurance (DQA) |
| Research & Development |
| Looks after the development-related functions by ensuring that the right product is developed, which is safe, pure and efficacious. |
|
| |
|
| Quality Assurance (QA) |
| Commercial |
| Assures that quality standards are maintained till the product reaches the patient. |
|
|
| |
| |
|
| "Our efforts are focused towards developing products that make a difference. We try to utilise resources as efficiently as possible to enable the progression of our assets while carrying out our R&D efforts" |
Raghav Chari
Senior Vice President,
Proprietary Products |
 |
|
